VINC
Vincerx Pharma Inc

1,981
Mkt Cap
$64,382.00
Volume
1,335.00
52W High
$10.37
52W Low
$0.0002
PE Ratio
0.00
VINC Fundamentals
Price
$0.0121
Prev Close
$0.0123
Open
$0.0121
50D MA
$0.0228
Beta
0.13
Avg. Volume
2,155.89
EPS (Annual)
-$15.85
P/B
0.03
Rev/Employee
$0.00
Loading...
Loading...
News
all
press releases
SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates VINC, MHLD, NEUE on Behalf of Shareholders
SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates VINC, MHLD, NEUE on Behalf of Shareholders SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates VINC, MHLD, NEUE on Behalf of Shareholders PR Newswire...
PR Newswire·11mo ago
News Placeholder
More News
News Placeholder
VINCERX PHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick and Foti, LLC Investigates Merger of Vincerx Pharma, Inc. - VINC
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (KSF) are investigating the proposed merger of Vincerx Pharma, Inc. (NasdaqCM: VINC) and...
Business Wire·11mo ago
News Placeholder
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates JWN, VINC, OMIC on Behalf of Shareholders
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates JWN, VINC, OMIC on Behalf of Shareholders SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates JWN, VINC, OMIC on Behalf of Shareholders...
PR Newswire·11mo ago
News Placeholder
Vincerx Pharma Stock Rises On Proposed Merger With Oqory: Retail Remains Bullish
Retail sentiment on Stocktwits has remained ‘bullish’ on the stock.
Stocktwits·1y ago
News Placeholder
Vincerx Pharma Stock Gets Retail Followers Buzzing With Big Layoff Plans To Sustain Cancer Drug Trials
The company's plans include a 55% reduction in force and exploring strategic alternatives such as out-licensing, mergers, or asset sales.
Stocktwits·1y ago

Latest VINC News

View

Advertisement|Remove ads.

Advertisement|Remove ads.